S. J. Carnahan-Craig

S. J. Carnahan-Craig

Auto-generated profile, based on publicly available information

S. J. Carnahan-Craig

Department of Biology, Penn State University, University Park, PA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSarah J. C. Craig
Sarah J. C. Craig
DBDaniel Blankenberg
Daniel Blankenberg
APAlice Carla Luisa Parodi
Alice Carla Luisa Parodi
IPIan M. Paul
Ian M. Paul
LBLeann L. Birch
Leann L. Birch
KMKateryna D. Makova
Kateryna D. Makova
Gut and oral microbiota perturbations have been observed in obese adults and adolescents; less is known about their influence on weight gain in young children. Here we analyzed the gut and oral microbiota of 226 two-year-olds with 16S rRNA gene sequencing. Weight and length were measured at seven time points and used to identify children with rapid infant weight gain (a strong risk factor for childhood obesity), and to derive growth curves with innovative Functional Data Analysis (FDA) techniques. We showed that growth curves were associated negatively with diversity, and positively with the Firmicutes-to-Bacteroidetes ratio, of the oral microbiota. We also demonstrated an association between the gut microbiota and child growth, even after controlling for the effect of diet on the microbiota. Lastly, we identified several bacterial genera that were associated with child growth patterns. These results suggest that by the age of two, the oral microbiota of children with rapid infant weight gain may have already begun to establish patterns often seen in obese adults. They also suggest that the gut microbiota at age two, while strongly influenced by diet, does not harbor obesity signatures many researchers identified in later life stages.

30 July 2021 in Pediatric Obesity
Verified
Journal Article
Open access
PDF file
DNDebmalya Nandy
Debmalya Nandy
SCSarah J. C. Craig
Sarah J. C. Craig
JCJingwei Cai
Jingwei Cai
YTYuan Tian
Yuan Tian
IPIan M. Paul
Ian M. Paul
FCFrancesca Chiaromonte
Francesca Chiaromonte
Summary: Background: Metabolomic analysis is commonly used to understand the biological underpinning of diseases such as obesity. However, our knowledge of gut metabolites related to weight outcomes in young children is currently limited.Objectives: To (1) explore the relationships between metabolites and child weight outcomes, (2) determine the potential effect of covariates (e.g., child's diet, maternal health/habits during pregnancy, etc.) in the relationship between metabolites and child weight outcomes, and (3) explore the relationship between selected gut metabolites and gut microbiota abundance.Methods: Using 1H‐NMR, we quantified 30 metabolites from stool samples of 170 two‐year‐old children. To identify metabolites and covariates associated with children's weight outcomes (BMI [weight/height2], BMI z‐score [BMI adjusted for age and sex], and growth index [weight/height]), we analysed the 1H‐NMR data, along with 20 covariates recorded on children and mothers, using LASSO and best subset selection regression techniques. Previously characterized microbiota community information from the same stool samples was used to determine associations between selected gut metabolites and gut microbiota.Results: At age 2 years, stool butyrate concentration had a significant positive association with child BMI (p‐value = 3.58 × 10–4), BMI z‐score (p‐value = 3.47 × 10–4), and growth index (p‐value = 7.73 × 10–4). Covariates such as maternal smoking during pregnancy are important to consider. Butyrate concentration was positively associated with the abundance of the bacterial genus Faecalibacterium (p‐value = 9.61 × 10−3).Conclusions: Stool butyrate concentration is positively associated with increased child weight outcomes and should be investigated further as a factor affecting childhood obesity.

27 November 2013 in Journal of Molecular Evolution
Verified
Journal Article
Closed access
PDF file
SCS. J. Carnahan-Craig
S. J. Carnahan-Craig
MJM. I. Jensen-Seaman
M. I. Jensen-Seaman

25 April 2024 in Journal of Developmental Origins of Health and Disease
Verified
Journal Article
Open access
PDF file
DLDelphine Lariviere
Delphine Lariviere
SCSarah J.C. Craig
Sarah J.C. Craig
IPIan M. Paul
Ian M. Paul
EHEmily E. Hohman
Emily E. Hohman
JSJennifer S. Savage
Jennifer S. Savage
MRMatthew L. Reimherr
Matthew L. Reimherr
Childhood obesity represents a significant global health concern and identifying its risk factors is crucial for developing intervention programs. Many “omics” factors associated with the risk of developing obesity have been identified, including genomic, microbiomic, and epigenomic factors. Here, using a sample of 48 infants, we investigated how the methylation profiles in cord blood and placenta at birth were associated with weight outcomes (specifically, conditional weight gain, body mass index, and weight-for-length ratio) at age six months. We characterized genome-wide DNA methylation profiles using the Illumina Infinium MethylationEpic chip, and incorporated information on child and maternal health, and various environmental factors into the analysis. We used regression analysis to identify genes with methylation profiles most predictive of infant weight outcomes, finding a total of 23 relevant genes in cord blood and 10 in placenta. Notably, in cord blood, the methylation profiles of three genes (PLIN4, UBE2F, and PPP1R16B) were associated with all three weight outcomes, which are also associated with weight outcomes in an independent cohort suggesting a strong relationship with weight trajectories in the first six months after birth. Additionally, we developed a Methylation Risk Score (MRS) that could be used to identify children most at risk for developing childhood obesity. While many of the genes identified by our analysis have been associated with weight-related traits (e.g., glucose metabolism, BMI, or hip-to-waist ratio) in previous genome-wide association and variant studies, our analysis implicated several others, whose involvement in the obesity phenotype should be evaluated in future functional investigations.

1 January 2023 in Econometrics and Statistics
Verified
Journal Article
Open access
SCSarah J.C. Craig
Sarah J.C. Craig
AKAna M. Kenney
Ana M. Kenney
JLJunli Lin
Junli Lin
IPIan M. Paul
Ian M. Paul
LBLeann L. Birch
Leann L. Birch
KMKateryna D. Makova
Kateryna D. Makova
Obesity is a highly heritable condition that affects increasing numbers of adults and, concerningly, of children. However, only a small fraction of its heritability has been attributed to specific genetic variants. These variants are traditionally ascertained from genome-wide association studies (GWAS), which utilize samples with tens or hundreds of thousands of individuals for whom a single summary measurement (e.g., BMI) is collected. An alternative approach is to focus on a smaller, more deeply characterized sample in conjunction with advanced statistical models that leverage longitudinal phenotypes. Novel functional data analysis (FDA) techniques are used to capitalize on longitudinal growth information from a cohort of children between birth and three years of age. In an ultra-high dimensional setting, hundreds of thousands of single nucleotide polymorphisms (SNPs) are screened, and selected SNPs are used to construct two polygenic risk scores (PRS) for childhood obesity using a weighting approach that incorporates the dynamic and joint nature of SNP effects. These scores are significantly higher in children with (vs. without) rapid infant weight gain-a predictor of obesity later in life. Using two independent cohorts, it is shown that the genetic variants identified in very young children are also informative in older children and in adults, consistent with early childhood obesity being predictive of obesity later in life. In contrast, PRSs based on SNPs identified by adult obesity GWAS are not predictive of weight gain in the cohort of young children. This provides an example of a successful application of FDA to GWAS. This application is complemented with simulations establishing that a deeply characterized sample can be just as, if not more, effective than a comparable study with a cross-sectional response. Overall, it is demonstrated that a deep, statistically sophisticated characterization of a longitudinal phenotype can provide increased statistical power to studies with relatively small sample sizes; and shows how FDA approaches can be used as an alternative to the traditional GWAS.

13 January 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DLDelphine Lariviere
Delphine Lariviere
SCSarah J.C. Craig
Sarah J.C. Craig
IPIan M. Paul
Ian M. Paul
EHEmily E. Hohman
Emily E. Hohman
JSJennifer S. Savage
Jennifer S. Savage
MRMatthew L. Reimherr
Matthew L. Reimherr
Childhood obesity represents a significant global health concern and identifying risk factors is crucial for developing intervention programs. Many ‘omics’ factors associated with the risk of developing obesity have been identified, including genomic, microbiomic, and epigenomic factors. Here, using a sample of 48 infants, we investigated how the methylation profiles in cord blood and placenta at birth were associated with weight outcomes (specifically, conditional weight gain, body mass index, and weight-for-length ratio) at age six months. We characterized genome-wide DNA methylation profiles using the Illumina Infinium MethylationEpic chip, and incorporated information on child and maternal health, and various environmental factors into the analysis. We used regression analysis to identify genes with methylation profiles most predictive of infant weight outcomes, finding a total of 23 relevant genes in cord blood and 10 in placenta. Notably, in cord blood, the methylation profiles of three genes ( PLIN4, UBE2F, and PPP1R16B ) were associated with all three weight outcomes, which are also associated with weight outcomes in an independent cohort suggesting a strong relationship with weight trajectories in the first six months after birth. Additionally, we developed a Methylation Risk Score (MRS) that could be used to identify children most at risk for developing childhood obesity. While many of the genes identified by our analysis have been associated with weight-related traits (e.g., glucose metabolism, BMI, or hip-to-waist ratio) in previous genome-wide association and variant studies, our analysis implicated several others, whose involvement in the obesity phenotype should be evaluated in future functional investigations.